Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV003492195 | SCV001139439 | likely benign | Hereditary cancer | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001057419 | SCV001221911 | uncertain significance | Fanconi anemia | 2022-10-24 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 803020). This variant has not been reported in the literature in individuals affected with FANCM-related conditions. This variant is present in population databases (rs771311008, gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 1313 of the FANCM protein (p.Ser1313Thr). |
Fulgent Genetics, |
RCV002489459 | SCV002797691 | uncertain significance | Spermatogenic failure 28; Premature ovarian failure 15 | 2021-08-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003148902 | SCV003837410 | uncertain significance | not provided | 2024-05-16 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |